| 000 | 02787 a2200697 4500 | ||
|---|---|---|---|
| 005 | 20250514160108.0 | ||
| 264 | 0 | _c20040217 | |
| 008 | 200402s 0 0 eng d | ||
| 022 | _a0893-133X | ||
| 024 | 7 |
_a10.1038/sj.npp.1300297 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBraga, Maria Fatima M | |
| 245 | 0 | 0 |
_aStress impairs alpha(1A) adrenoceptor-mediated noradrenergic facilitation of GABAergic transmission in the basolateral amygdala. _h[electronic resource] |
| 260 |
_bNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology _cJan 2004 |
||
| 300 |
_a45-58 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. | ||
| 650 | 0 | 4 |
_a2-Amino-5-phosphonovalerate _xpharmacology |
| 650 | 0 | 4 |
_a6-Cyano-7-nitroquinoxaline-2,3-dione _xpharmacology |
| 650 | 0 | 4 |
_aAdrenergic alpha-Antagonists _xpharmacology |
| 650 | 0 | 4 |
_aAdrenergic beta-Antagonists _xpharmacology |
| 650 | 0 | 4 | _aAging |
| 650 | 0 | 4 |
_aAmygdala _xcytology |
| 650 | 0 | 4 |
_aAnesthetics, Local _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aAnimals, Newborn |
| 650 | 0 | 4 |
_aBicuculline _xpharmacology |
| 650 | 0 | 4 | _aBody Weight |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 |
_aEstrenes _xpharmacology |
| 650 | 0 | 4 | _aExcitatory Amino Acid Antagonists |
| 650 | 0 | 4 |
_aGABA Antagonists _xpharmacology |
| 650 | 0 | 4 |
_aImidazoles _xpharmacology |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aIsoquinolines _xmetabolism |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMembrane Potentials _xdrug effects |
| 650 | 0 | 4 |
_aMorpholines _xpharmacology |
| 650 | 0 | 4 |
_aNeural Inhibition _xdrug effects |
| 650 | 0 | 4 |
_aNeurons _xdrug effects |
| 650 | 0 | 4 |
_aNorepinephrine _xpharmacology |
| 650 | 0 | 4 |
_aPatch-Clamp Techniques _xmethods |
| 650 | 0 | 4 |
_aPhosphodiesterase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aPropranolol _xpharmacology |
| 650 | 0 | 4 |
_aPyrrolidinones _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aReceptors, Adrenergic, alpha-1 _xmetabolism |
| 650 | 0 | 4 |
_aRestraint, Physical _xmethods |
| 650 | 0 | 4 |
_aStress, Physiological _xmetabolism |
| 650 | 0 | 4 |
_aTetrahydronaphthalenes _xpharmacology |
| 650 | 0 | 4 |
_aTetrodotoxin _xpharmacology |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_agamma-Aminobutyric Acid _xmetabolism |
| 700 | 1 | _aAroniadou-Anderjaska, Vassiliki | |
| 700 | 1 | _aManion, Sean T | |
| 700 | 1 | _aHough, Christopher J | |
| 700 | 1 | _aLi, He | |
| 773 | 0 |
_tNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology _gvol. 29 _gno. 1 _gp. 45-58 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.npp.1300297 _zAvailable from publisher's website |
| 999 |
_c14292178 _d14292178 |
||